Optas LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$404K Sell
907
-875
-49% -$390K 0.08% 168
2025
Q1
$864K Buy
1,782
+908
+104% +$440K 0.15% 74
2024
Q4
$352K Buy
874
+64
+8% +$25.8K 0.08% 153
2024
Q3
$377K Buy
810
+37
+5% +$17.2K 0.09% 141
2024
Q2
$362K Buy
773
+19
+3% +$8.91K 0.09% 119
2024
Q1
$315K Buy
754
+9
+1% +$3.76K 0.09% 135
2023
Q4
$303K Buy
745
+10
+1% +$4.07K 0.09% 134
2023
Q3
$256K Buy
735
+19
+3% +$6.61K 0.09% 139
2023
Q2
$252K Buy
716
+9
+1% +$3.17K 0.08% 137
2023
Q1
$223K Buy
+707
New +$223K 0.08% 144
2020
Q4
Sell
-1,351
Closed -$367K 174
2020
Q3
$367K Buy
1,351
+469
+53% +$127K 0.11% 112
2020
Q2
$256K Sell
882
-135
-13% -$39.2K 0.1% 103
2020
Q1
$241K Buy
1,017
+9
+0.9% +$2.13K 0.12% 111
2019
Q4
$220K Buy
+1,008
New +$220K 0.08% 140